医学
神经纤维瘤病
替莫唑胺
胶质母细胞瘤
放射治疗
化疗
纤维神经瘤
星形细胞瘤
放射科
肿瘤科
外科
癌症研究
作者
Tayfun Hakan,Fügen Aker
出处
期刊:PubMed
日期:2008-11-01
卷期号:42 (4): 362-5
被引量:12
摘要
Neurofibromatosis type 1 (NF1) is one of the most common dominantly inherited disorders. Astrocytomas, especially low-grade optic nerve tumours, are frequently harboured in these patients. In this paper, a case of a lobar cystic glioblastoma and NF1 in a 28-year-old woman is presented. This patient underwent a resection of the glioblastoma, followed a multimodal therapy including radiotherapy and chemotherapy, and survived 41 months. Neurofibromatosis is a multifaceted disease in which primary malignant CNS tumours, such as glioblastoma, can be identified. Glioblastomas in these patients should be managed like the usual ones. They may benefit from treatment with temozolomide, as can GBM patients without NF, thus potentially increasing the patient's overall survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI